Description

Fisher & Paykel's Wigglepads Optiflow Junior is a specialized accessory designed to enhance the effectiveness of nasal high flow (NHF) therapy for pediatric patients, including neonates, infants, and children. These adhesive pads are crafted to secure the Optiflow Junior 2 nasal cannulas, ensuring stability and comfort during therapy.

Key Features

• Secure Attachment: The Wigglepads adhere to the patient's cheeks, maintaining the position of the cannula and reducing movement, which is crucial for effective therapy.
• Custom Fit: Each pad conforms to the unique shape of the Optiflow Junior 2 cannula, allowing for easy application, adjustment, and removal.
• Hygienic Design: As a single-use item, the pads are intended for one-time use, promoting hygiene and preventing cross-contamination.

FlexiTube Technology

Part of the cannula system, the kink-proof and crush-resistant FlexiTube enhances durability and performance. The tube is color-coded for easy size identification, available in sizes XS, S, M, L, XL, and XXL, aligning with the corresponding cannula sizes.

Instructions for Use

• Application: Gently peel the cannula from the Wigglepads, clean the patient’s skin and the pad’s underside with a damp cloth, and adhere the replacement pads following the provided instructions.
• Precautions: Ensure the prongs do not seal in the nares and use patient weight as a guide for size selection.

Packaging

The product is packaged with 2 pads per pack for sizes XS to XL, and 1 pad per pack for size XXL, with 20 packs per box. This thoughtful packaging design caters to various clinical needs and ensures convenient replenishment.

Compliance and Safety

Wigglepads Optiflow Junior complies with multiple medical device standards, including IEC 60601-1 and its equivalents, ensuring safety and electromagnetic compatibility. This compliance underscores its reliability as a medical accessory for respiratory support.

By providing a secure and comfortable fit for the Optiflow Junior 2 cannulas, Wigglepads Optiflow Junior plays a vital role in delivering consistent and effective NHF therapy, enhancing patient outcomes in clinical settings.